Arbejdsgruppen mødtes to gange, og alle planlagte nye retningslinjer er nu færdiggjorte.
Furthermore the group made good progress in the preparation of new guidance on causality assessment, the triggering of regulatory action through pharmacovigilance, and on the calculation of incidence in PSURs. • Safety Working Party